QA: ABBOTT LABORATORIES in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000001800_2020_ABBOTT_LABORATORIES.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000001800, ABBOTT LABORATORIES

  xvar xval
0 AssetsCurrent 15,667,000,000
1 IntangibleAssetsNetIncludingGoodwill 40,220,000,000
2 PropertyPlantAndEquipmentNet 8,038,000,000
3 remainder_Assets 3,962,000,000
4 LiabilitiesCurrent 10,863,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 13,231,000,000
8 SellingGeneralAndAdministrativeExpense 9,765,000,000
9 ResearchAndDevelopmentExpense 2,440,000,000
10 remainder_Expenses 2,996,000,000
11 remainder_Revenues 31,904,000,000
12 remainder_NetIncome 215,000,000
13 remainder_ComprehensiveNetIncome -879,000,000
  yvar yval
0 Assets 67,887,000,000
1 Liabilities 10,863,000,000
2 Expenses 28,432,000,000
3 Revenues 31,904,000,000
4 StockholdersEquity 57,024,000,000
5 NetIncome 3,687,000,000
6 ComprehensiveNetIncome 3,247,500,000
7 BaseVar 70,090,000,000
8 EconomicCapitalRatio 2.57

Edgar->Model Mapping

Feature Distribution

Change over Time